Loading insider details...
Beta
Latest Form 4 (Jan 23, 2026): Disposition to Issuer of 80,000 ATXS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 23, 2026 | Astria Therapeutics, Inc. (ATXS) | Disposition to Issuer | 80,000 | n/a |
| Mar 25, 2025 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 262,500 | n/a |
| Apr 3, 2024 | Astria Therapeutics, Inc. (ATXS) | Exercise/Conversion | 10,000 | $38.7K |
| Feb 12, 2024 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 175,000 | n/a |
| Jan 30, 2024 | Astria Therapeutics, Inc. (ATXS) | Exercise/Conversion | 800 | $3.1K |
| Jun 6, 2023 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 90,000 | n/a |
| Aug 2, 2022 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 100,000 | n/a |
| Jan 21, 2022 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 59,744 | n/a |
| Jun 29, 2021 | Fulcrum Therapeutics, Inc. (FULC) | Purchase | 1,100 | $10.1K |
| May 12, 2021 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 163,000 | n/a |